Trend — Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (A9552) in Medicare, the United States

The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.

The compound annual growth for A9552 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.